521![PBTC-025 v1.0 Version Date: [removed]Protocol Abstract and Schema Phase I study of the Smoothened (SMO) antagonist GDC-0449 for recurrent or refractory medulloblastoma PBTC-025 v1.0 Version Date: [removed]Protocol Abstract and Schema Phase I study of the Smoothened (SMO) antagonist GDC-0449 for recurrent or refractory medulloblastoma](https://www.pdfsearch.io/img/1a9d1f68ac775b21c68a72947d9e1e51.jpg) | Add to Reading ListSource URL: www.pbtc.orgLanguage: English - Date: 2009-02-17 14:38:02
|
---|
522![Fertility / Leuprorelin / TAP Pharmaceuticals / Gonadotropin-releasing hormone agonist / In vitro fertilisation / Fertility medication / Endometriosis / Assisted reproductive technology / Gonadotropin-releasing hormone antagonist / Fertility medicine / Human reproduction / Medicine Fertility / Leuprorelin / TAP Pharmaceuticals / Gonadotropin-releasing hormone agonist / In vitro fertilisation / Fertility medication / Endometriosis / Assisted reproductive technology / Gonadotropin-releasing hormone antagonist / Fertility medicine / Human reproduction / Medicine](/pdf-icon.png) | Add to Reading ListSource URL: www.humanebiotech.comLanguage: English - Date: 2014-09-21 02:19:17
|
---|
523![P harmacology gs_ASME_Book P harmacology gs_ASME_Book](https://www.pdfsearch.io/img/6b10a7d0de27b468f55f08ab3b3e5b5d.jpg) | Add to Reading ListSource URL: www.nattc.orgLanguage: English - Date: 2008-05-14 10:27:54
|
---|
524![U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived](https://www.pdfsearch.io/img/cadbecfdaa24cf40f99e5af1a28a63ee.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
525![The Targeting Acute Congestion with Tolvaptan In Congestive Heart Failure Study TACTICS-HF Felker GM, Adams KF, Cole RT, Patel CB, Egnaczyk G, Mentz RJ, Fiuzat M, and O’Connor CM on behalf of the TACTICS Investigators The Targeting Acute Congestion with Tolvaptan In Congestive Heart Failure Study TACTICS-HF Felker GM, Adams KF, Cole RT, Patel CB, Egnaczyk G, Mentz RJ, Fiuzat M, and O’Connor CM on behalf of the TACTICS Investigators](https://www.pdfsearch.io/img/3447eb4f976316d9a2ff2aa7c320197e.jpg) | Add to Reading ListSource URL: www.hfsa.orgLanguage: English - Date: 2013-10-11 12:59:07
|
---|
526![Non-Classical Antihistamines Non-Classical Antihistamines](https://www.pdfsearch.io/img/751a8c9eeb74bb0c0cbb4f3a3139c937.jpg) | Add to Reading ListSource URL: www.hc-sc.gc.caLanguage: English - Date: 2013-07-12 14:25:53
|
---|
527![Oral Antiemetic Agents (except Cesamet and Emend) (See separate Summary Sheets for Cesamet and Emend Coverage Policies) Covered medications Dolasetron (Anzemet), Granisetron (Kytril, Granisol™ oral solution Oral Antiemetic Agents (except Cesamet and Emend) (See separate Summary Sheets for Cesamet and Emend Coverage Policies) Covered medications Dolasetron (Anzemet), Granisetron (Kytril, Granisol™ oral solution](https://www.pdfsearch.io/img/e15626201a3716545a96406d06746be5.jpg) | Add to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2013-10-03 14:58:45
|
---|
528![EPA www.epa.gov Use of Novel Assays to Screen Large Chemical Inventories for Functional Estrogen Receptor (ER) Activity Keith Houck1, Matt Martin1, Richard Judson1, Daniel Rotroff1, Jon Melnick2, Jane Lamedin2, John West EPA www.epa.gov Use of Novel Assays to Screen Large Chemical Inventories for Functional Estrogen Receptor (ER) Activity Keith Houck1, Matt Martin1, Richard Judson1, Daniel Rotroff1, Jon Melnick2, Jane Lamedin2, John West](https://www.pdfsearch.io/img/406e0a0643c001511cb5584460887b1b.jpg) | Add to Reading ListSource URL: www.epa.govLanguage: English - Date: 2013-04-10 16:29:24
|
---|
529![Network Model of the Estrogen Receptor Pathway: Integrating a Battery of In Vitro HTS Assays Richard Judson(1), Felicia Maria Magpantay(2), Vijay Chickarmane(3), Cymra Haskell(4), Nessy Tania(5), Jean Taylor(6), Daniel R Network Model of the Estrogen Receptor Pathway: Integrating a Battery of In Vitro HTS Assays Richard Judson(1), Felicia Maria Magpantay(2), Vijay Chickarmane(3), Cymra Haskell(4), Nessy Tania(5), Jean Taylor(6), Daniel R](https://www.pdfsearch.io/img/0604a66c551f6ce60a39d1a305abd397.jpg) | Add to Reading ListSource URL: www.epa.govLanguage: English - Date: 2013-04-10 16:29:19
|
---|
530![Mississippi Division Of Medicaid Preferred Drug List Changes PDL Changes Effective Date: August 1, 2014 The following changes will be made to the Preferred Drug List (PDL), effective August 1, 2014, pending recommendatio Mississippi Division Of Medicaid Preferred Drug List Changes PDL Changes Effective Date: August 1, 2014 The following changes will be made to the Preferred Drug List (PDL), effective August 1, 2014, pending recommendatio](https://www.pdfsearch.io/img/3df2ae2bd413ab1c599521096713404e.jpg) | Add to Reading ListSource URL: www.medicaid.ms.govLanguage: English - Date: 2014-07-10 10:31:58
|
---|